Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Clinical Immunology (Orlando, Fla.)
|
April 16, 2011
Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide
Andrew E Hogan, Vincent O'Reilly, Margaret R Dunne, et al.
Scientific Reports
|
May 8, 2023
Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibition
Bandar Alharbi, Husam Qanash, Naif K Binsaleh, et al.
Clinical Immunology (Orlando, Fla.)
|
July 17, 2021
Tissue distribution of γδ T cell subsets in oesophageal adenocarcinoma
Ashanty M Melo, Eimear Mylod, Vivienne Fitzgerald, et al.
Open Forum Infectious Diseases
|
November 19, 2025
Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential
Vasile Mihai Sularea, Liam Townsend, Cian Reid, et al.
Glycobiology
|
April 25, 2018
Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells
Ashanty M Melo, Lei Zhang, Éilis F Dockry, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 17, 2015
Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity
Eirin Carolan, Laura M Tobin, Bozgana A Mangan, et al.
Plos One
|
April 20, 2026
Upregulation of CD1d and ULBP3 on B cells from healthy donors and chronic lymphocytic leukaemia patients does not prime them for killing by γδ T cells
Julie David, Amy Walsh, Ke Sin Seow, et al.
Mediators of Inflammation
|
October 16, 2019
Altered Toll-Like Receptor Signalling in Children with Down Syndrome
Dean Huggard, W J Koay, Lynne Kelly, et al.
Cancer Letters
|
January 18, 2018
Extratumoral PD-1 blockade does not perpetuate obesity-associated inflammation in esophageal adenocarcinoma
Karen C Galvin, Melissa J Conroy, Suzanne L Doyle, et al.
Translational Oncology
|
February 18, 2025
Adipose tissue from oesophageal adenocarcinoma patients is differentially affected by chemotherapy and chemoradiotherapy regimens altering immune cell phenotype and cancer cell metabolism
Fiona O'Connell, Eimear Mylod, Noel E Donlon, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Clinical Immunology (Orlando, Fla.)
|
April 16, 2011
Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide
Andrew E Hogan, Vincent O'Reilly, Margaret R Dunne, et al.
Scientific Reports
|
May 8, 2023
Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibition
Bandar Alharbi, Husam Qanash, Naif K Binsaleh, et al.
Clinical Immunology (Orlando, Fla.)
|
July 17, 2021
Tissue distribution of γδ T cell subsets in oesophageal adenocarcinoma
Ashanty M Melo, Eimear Mylod, Vivienne Fitzgerald, et al.
Open Forum Infectious Diseases
|
November 19, 2025
Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential
Vasile Mihai Sularea, Liam Townsend, Cian Reid, et al.
Glycobiology
|
April 25, 2018
Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells
Ashanty M Melo, Lei Zhang, Éilis F Dockry, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 17, 2015
Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity
Eirin Carolan, Laura M Tobin, Bozgana A Mangan, et al.
Plos One
|
April 20, 2026
Upregulation of CD1d and ULBP3 on B cells from healthy donors and chronic lymphocytic leukaemia patients does not prime them for killing by γδ T cells
Julie David, Amy Walsh, Ke Sin Seow, et al.
Mediators of Inflammation
|
October 16, 2019
Altered Toll-Like Receptor Signalling in Children with Down Syndrome
Dean Huggard, W J Koay, Lynne Kelly, et al.
Cancer Letters
|
January 18, 2018
Extratumoral PD-1 blockade does not perpetuate obesity-associated inflammation in esophageal adenocarcinoma
Karen C Galvin, Melissa J Conroy, Suzanne L Doyle, et al.
Translational Oncology
|
February 18, 2025
Adipose tissue from oesophageal adenocarcinoma patients is differentially affected by chemotherapy and chemoradiotherapy regimens altering immune cell phenotype and cancer cell metabolism
Fiona O'Connell, Eimear Mylod, Noel E Donlon, et al.
Page
of 8